It has been shown that the level of PTEN in the substantia nigra of patients with Parkinson’s disease is significantly increased, which is associated with enhanced neurodegeneration [128], and an increase in the content of PTEN increases brain damage after ischemia/reperfusion [129]. The gene discussed is PTEN; the disease is Parkinson disease.